Makiko Nakayama
Overview
Explore the profile of Makiko Nakayama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
1231
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hayashi I, Keino H, Nakayama M, Ando Y, Watanabe T, Okada A
Ocul Immunol Inflamm
. 2025 Jan;
1-9.
PMID: 39792467
Purpose: This study aimed to investigate demographic features, diagnoses of uveitis (intraocular inflammation), and real-world clinical practice in the use of local and systemic therapies for patients with uveitis in...
2.
Hatakeyama C, Kataoka K, Yoshikawa Y, Nakayama M, Yamamoto A, Okada A
Retina
. 2024 Dec;
45(3):548-554.
PMID: 39622252
Purpose: To identify the clinical parameters predictive of persistent subretinal fluid in acute central serous chorioretinopathy (CSC). Methods: Clinical data of consecutive eyes diagnosed with first-time, acute, treatment-naïve CSC followed...
3.
Mukai R, Kataoka K, Tanaka K, Miyara Y, Maruko I, Nakayama M, et al.
Sci Rep
. 2024 May;
14(1):11681.
PMID: 38778065
This multicentre retrospective study evaluated the 1-year outcomes and safety profile of faricimab in treatment-naïve patients with neovascular age-related macular degeneration (nAMD). Fifty-five patients (57 eyes) underwent loading therapy comprising...
4.
Kumagai N, Oikawa Y, Nakayama M, Kasajima A, Joh K
J Nephrol
. 2024 Mar;
37(3):807-810.
PMID: 38512369
No abstract available.
5.
Tomita U, Ishimoto Y, Ri M, Kawase Y, Hizukuri Y, Maru C, et al.
Sci Rep
. 2024 Mar;
14(1):5135.
PMID: 38429446
G-protein-coupled receptor class 5 member D (GPRC5D) is detected in malignant plasma cells in approximately 90% of patients diagnosed with multiple myeloma (MM). Here, we constructed BsAb5003, a novel humanized...
6.
Inoda S, Takahashi H, Maruyama-Inoue M, Ikeda S, Sekiryu T, Itagaki K, et al.
Retina
. 2023 Nov;
44(4):714-722.
PMID: 38016089
Purpose: To investigate the incidence of intraocular inflammation (IOI) and its risk factors following intravitreal injections of brolucizumab for neovascular age-related macular degeneration in Japan. Methods: A total of 1,351...
7.
Kataoka K, Itagaki K, Hashiya N, Wakugawa S, Tanaka K, Nakayama M, et al.
Graefes Arch Clin Exp Ophthalmol
. 2023 Sep;
262(1):43-51.
PMID: 37668741
Purpose: To assess 6-month outcomes of switching from aflibercept to faricimab in eyes with refractory neovascular age-related macular degeneration (nAMD) previously requiring monthly injections. Methods: This multicenter retrospective study examined...
8.
Kumagai N, Matsuki T, Nakayama M
Tohoku J Exp Med
. 2023 Aug;
261(3):195-198.
PMID: 37635062
We report an infant case of transient distal renal tubular acidosis and Fanconi syndrome caused by rotavirus gastroenteritis. A 10-month-old boy was admitted to the hospital because of frequent vomiting,...
9.
Schierbaum L, Schneider S, Buerger F, Halawi A, Seltzsam S, Wang C, et al.
Nephron
. 2023 Jul;
147(11):685-692.
PMID: 37499630
Introduction: Congenital anomalies of the kidney and urinary tract (CAKUT) are the most common cause of chronic kidney disease in the first 3 decades of life. Over 40 genes have...
10.
Mukai R, Kataoka K, Tanaka K, Miyara Y, Maruko I, Nakayama M, et al.
Sci Rep
. 2023 May;
13(1):8747.
PMID: 37253802
This multicenter study aimed to assess the short-term effectiveness and safety of faricimab in treatment-naïve patients with wet age-related macular degeneration (wAMD) in Japan. We retrospectively reviewed 63 eyes of...